Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase 1 4Phase NA 3Phase 3 2Phase 1/2 2Phase 2/3 1

Status

Unknown 16Active not recruiting 4Recruiting 3Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Gastrointestinal 1

Conditions

Peritoneal Neoplasms 2Stomach Neoplasms 1Krukenberg Tumor 1

Interventions

Cyclophosphamide 297Cisplatin 297Paclitaxel 258Radiotherapy 253Fluorouracil 234Carboplatin 234Docetaxel 231Doxorubicin 212Dexamethasone 164Gemcitabine 155Vincristine 143Etoposide 133Leucovorin 132Capecitabine 129Bevacizumab 129Prednisone 124Rituximab 118Methotrexate 117Cytarabine 108Filgrastim 99Trastuzumab 98Oxaliplatin 96pembrolizumab 81Pemetrexed 73Epirubicin 70Tamoxifen 69Drug Therapy 69Irinotecan 65Granulocyte Colony-Stimulating Factor 60Nivolumab 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Completed × Hyperthermic Intraperitoneal Chemotherapy × Clear all
NCT01226394 2026-04-06

ProphyloCHIP

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Completed
150 enrolled
Gynecologic

Krukenberg Tumor, Peritoneal Neoplasms

NCT02158988 2021-07-29

GASTRIPEC

Charite University, Berlin, Germany

Phase 3 Completed
105 enrolled
GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡